Peer, N.
Lombard, C.
Steyn, K.
Levitt, N.
Article History
Received: 4 December 2019
Accepted: 25 February 2020
First Online: 12 March 2020
Competing interests
: Naomi Levitt has received honoraria from Novartis for serving on the steering committee for the Navigator Trial and travel support from Novo Nordisk, Eli Lilly Laboratories and Sanofi Aventis. All other authors report no potential conflicts of interest, including specific financial interests, relevant to the subject of this manuscript.